Mathias Viard Selected Research

Mathias Viard Research Topics

Disease

7	Neoplasms (Cancer) 01/2023 - 03/2013
6	Infections 01/2024 - 01/2004
6	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2015
2	HIV Infections (HIV Infection) 01/2024 - 01/2019
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2024 - 11/2020
2	Urinary Bladder Neoplasms (Bladder Cancer) 12/2022 - 01/2022
2	Melanoma (Melanoma, Malignant) 11/2018 - 01/2004
1	Osteosarcoma (Osteogenic Sarcoma) 01/2023
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2023
1	Sarcoma (Soft Tissue Sarcoma) 01/2023
1	Glioma (Gliomas) 01/2023
1	Rhabdomyosarcoma 01/2023
1	Malaria 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Parasitemia 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2020
1	Esophageal Neoplasms (Esophageal Cancer) 05/2019
1	Disease Progression 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 10/2016
1	Human Influenza (Influenza) 03/2012
1	Virus Diseases (Viral Diseases) 05/2008

Drug/Important Bio-Agent (IBA)

4	RNA (Ribonucleic Acid)IBA 01/2023 - 03/2016
4	Small Interfering RNA (siRNA)IBA 06/2020 - 01/2015
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2024 - 12/2022
3	VaccinesIBA 01/2022 - 05/2008
3	Peptides (Polypeptides)IBA 01/2022 - 11/2012
3	LipidsIBA 10/2018 - 01/2015
2	EpitopesIBA 01/2024 - 01/2023
2	HLA-B Antigens (HLA-B)IBA 01/2024 - 01/2023
2	HLA-A Antigens (HLA-A)IBA 01/2024 - 01/2022
2	tapasinIBA 01/2022 - 11/2020
2	Glycoproteins (Glycoprotein)IBA 12/2005 - 01/2004
2	GlycosphingolipidsIBA 01/2004 - 01/2004
1	transporter associated with antigen processing (TAP)IBA 01/2023
1	Histocompatibility Antigens Class IIBA 01/2023
1	AntigensIBA 01/2023
1	Histocompatibility Antigens Class IIIBA 01/2023
1	HLA-DR Antigens (HLA-DR)IBA 01/2023
1	B7-H1 AntigenIBA 12/2022
1	Programmed Cell Death 1 ReceptorIBA 12/2022
1	NivolumabIBA 01/2022
1	Sunitinib (Sutent)FDA Link 01/2022
1	Everolimus FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	avelumabIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Axitinib (AG 013736)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 11/2021
1	KIR ReceptorsIBA 01/2021
1	LigandsIBA 01/2021
1	HLA-C Antigens (HLA-C)IBA 01/2021
1	bolaamphiphileIBA 06/2020
1	PolymersIBA 01/2020
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2020
1	chlorinIBA 05/2019
1	2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH)IBA 05/2019
1	Photosensitizing Agents (Photosensitizers)IBA 05/2019
1	pyropheophorbide aIBA 05/2019
1	Long Noncoding RNAIBA 01/2019
1	CCR5 Receptors (CCR5 Receptor)IBA 01/2019
1	NucleotidesIBA 11/2018
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2018
1	OximesIBA 01/2015
1	Ether (Diethyl Ether)IBA 01/2015
1	Hydroxyl RadicalIBA 01/2015
1	Antiviral Agents (Antivirals)IBA 11/2012
1	safingol (sphinganine)IBA 11/2012
1	Detergents (Detergent)IBA 03/2012
1	Neuraminidase (Sialidase)IBA 05/2008

Therapy/Procedure

3	Immunotherapy 01/2024 - 12/2022
2	Therapeutics 01/2022 - 03/2013
1	Precision Medicine 01/2023
1	Aftercare (After-Treatment) 01/2022
1	Drug Therapy (Chemotherapy) 10/2018